Exploring the Results From a Pair of Pivotal Phase 3 Trials and Their Long-term Extension Study

• Read the infographic

Exploring the Results of a Subgroup Analysis in Patients Aged ≥65 Years

• Read the infographic

A Retrospective Observational Analysis

• Read the infographic

Presenters: Dr. Gary Zammit, Clinical Professor of Psychiatry at the Icahn School of Medicine at Mount Sinai and CEO of Clinilabs Development Corporation

Watch Dr. Zammit as he discusses key findings from two Phase 3 clinical trials and the long term extension study evaluating the efficacy and safety of daridorexant in the treatment of adult patients with insomnia.

Presenter: Dr. Paul Saskin, Medical Director, Insomnia for Idorsia

Watch Dr. Saskin discuss the findings from a trial evaluating the long-term safety and efficacy of daridorexant.

Presenter: Dr. Scott G. Williams, Deputy Director for Medicine at Fort Belvoir Community Hospital

Watch Dr. Williams discuss a real-world study evaluating patients who had started on or switched to daridorexant.

This report summarizes the key results from the two Phase 3 clinical trials and long term extension study evaluating the safety and efficacy of daridorexant in adult patients with insomnia.

• Read the summary

Please find published literature on daridorexant on PubMed using the link below. 

• View a bibliography of published manuscripts on Daridorexant and Insomnia

If you would like to request any publications, please submit a medical information request.

• Request a publication